Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction

NCT00502528 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

ST-Elevation Myocardial Infarction

Interventions

DRUG: Placebo
DRUG: BQ-123

Sponsor

Medical University of Vienna